Archive | December, 2017

Sunovion Receives FDA Approval for Lonhala Magnair (glycopyrrolate) Inhalation Solution to Treat COPD

In continuation of my update on glycopyrrolate Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S. Food and Drug Administration (FDA) approved the New Drug Application (NDA) for Lonhala Magnair (glycopyrrolate) Inhalation Solution (25 mcg twice daily), also known as SUN-101/eFlow®, for the long-term, maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary […]

Continue Reading

New patent expiration for Novartis drug DIOVAN HCT

Annual Drug Patent Expirations for DIOVAN+HCT Diovan Hct is a drug marketed by Novartis and is included in one NDA. It is available from nine suppliers. There is one patent… The post New patent expiration for Novartis drug DIOVAN HCT appeared first on DrugPatentWatch. The post New patent expiration for Novartis drug DIOVAN HCT appeared […]

Continue Reading

New patent expiration for Novartis drug DIOVAN

Annual Drug Patent Expirations for DIOVAN Diovan is a drug marketed by Novartis and is included in three NDAs. It is available from ten suppliers. There are two patents protecting… The post New patent expiration for Novartis drug DIOVAN appeared first on DrugPatentWatch. The post New patent expiration for Novartis drug DIOVAN appeared first on […]

Continue Reading

New patent expiration for Genentech Inc drug ESBRIET

Annual Drug Patent Expirations for ESBRIET Esbriet is a drug marketed by Genentech Inc and is included in two NDAs. It is available from two suppliers. There are twenty patents… The post New patent expiration for Genentech Inc drug ESBRIET appeared first on DrugPatentWatch. The post New patent expiration for Genentech Inc drug ESBRIET appeared […]

Continue Reading

Drug Patent Expirations for the Week of December 17, 2017

QVAR 80 (beclomethasone dipropionate) Teva branded pharm Patent: 6,446,627 Expiration: Dec 18, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,… The post Drug Patent Expirations for the Week of December 17, 2017 appeared first on DrugPatentWatch. The post Drug Patent Expirations for the Week of […]

Continue Reading

New patent expiration for Novartis drug EXFORGE

Annual Drug Patent Expirations for EXFORGE Exforge is a drug marketed by Novartis and is included in two NDAs. It is available from three suppliers. There are four patents protecting… The post New patent expiration for Novartis drug EXFORGE appeared first on DrugPatentWatch. The post New patent expiration for Novartis drug EXFORGE appeared first on […]

Continue Reading

New patent expiration for Teva Pharm drug ARMONAIR RESPICLICK

Annual Drug Patent Expirations for ARMONAIR+RESPICLICK Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are fourteen… The post New patent expiration for Teva Pharm drug ARMONAIR RESPICLICK appeared first on DrugPatentWatch. The post New patent expiration for Teva Pharm drug ARMONAIR […]

Continue Reading

New patent expiration for Novartis drug EXFORGE HCT

Annual Drug Patent Expirations for EXFORGE+HCT Exforge Hct is a drug marketed by Novartis and is included in one NDA. It is available from three suppliers. There are three patents… The post New patent expiration for Novartis drug EXFORGE HCT appeared first on DrugPatentWatch. The post New patent expiration for Novartis drug EXFORGE HCT appeared […]

Continue Reading

New patent expiration for Teva Pharm drug AIRDUO RESPICLICK

Annual Drug Patent Expirations for AIRDUO+RESPICLICK Airduo Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from two suppliers. There are sixteen… The post New patent expiration for Teva Pharm drug AIRDUO RESPICLICK appeared first on DrugPatentWatch. The post New patent expiration for Teva Pharm drug AIRDUO […]

Continue Reading

New patent expiration for Norton Waterford drug QVAR REDIHALER

Annual Drug Patent Expirations for QVAR+REDIHALER Qvar Redihaler is a drug marketed by Norton Waterford and is included in one NDA. There are four patents protecting this drug. This drug… The post New patent expiration for Norton Waterford drug QVAR REDIHALER appeared first on DrugPatentWatch. The post New patent expiration for Norton Waterford drug QVAR […]

Continue Reading